These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30271651)

  • 1. Successful Renal Transplantation after Presumed Cyanide Toxicity Treated with Hydroxocobalamin and Review of the Literature.
    Hendrix RJ; Martins PN; Stoff JS; Ahearn A; Bozorgzadeh A; Movahedi B
    Case Rep Transplant; 2018; 2018():3753479. PubMed ID: 30271651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful organ transplantation after treatment of fatal cyanide poisoning with hydroxocobalamin.
    Fortin JL; Ruttimann M; Capellier G; Bigorie A; Ferlicot S; Thervet E
    Clin Toxicol (Phila); 2007; 45(5):468-71. PubMed ID: 17503248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Hydroxocobalamin-Induced False Blood Leak Alarm on Dialysis Machine.
    Datar P; Sidhu JS; Virk J; Mukhtar O; Schmidt F; Gayam V
    J Investig Med High Impact Case Rep; 2019; 7():2324709619883466. PubMed ID: 31701774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prehospital hydroxocobalamin for inhalation injury and cyanide toxicity in the United States - analysis of a database and survey of ems providers.
    Purvis MV; Rooks H; Young Lee J; Longerich S; Kahn SA
    Ann Burns Fire Disasters; 2017 Jun; 30(2):126-128. PubMed ID: 29021725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoke inhalation injury in a pregnant patient: a literature review of the evidence and current best practices in the setting of a classic case.
    Roderique EJ; Gebre-Giorgis AA; Stewart DH; Feldman MJ; Pozez AL
    J Burn Care Res; 2012; 33(5):624-33. PubMed ID: 22293595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost impact of hydroxocobalamin in the treatment of patients with known or suspected cyanide poisoning due to smoke inhalation from closed-space fires.
    Sanders KN; Aggarwal J; Stephens JM; Michalopoulos SN; Dalton D; Lewis DE; Kahn SA
    Burns; 2022 Sep; 48(6):1325-1330. PubMed ID: 34903402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation.
    Borron SW; Baud FJ; Barriot P; Imbert M; Bismuth C
    Ann Emerg Med; 2007 Jun; 49(6):794-801, 801.e1-2. PubMed ID: 17481777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis failure secondary to hydroxocobalamin exposure.
    Lim K; Heher E; Steele D; Fenves AZ; Tucker JK; Thadhani R; Christopher K; Tolkoff-Rubin N
    Proc (Bayl Univ Med Cent); 2017 Apr; 30(2):167-168. PubMed ID: 28405068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm.
    Cheungpasitporn W; Hui J; Kashani KB; Wittwer ED; Albright RC; Dillon JJ
    Clin Kidney J; 2017 Jun; 10(3):357-362. PubMed ID: 28616214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of cyanide antidote use since regulatory approval of hydroxocobalamin in the United States.
    Streitz MJ; Bebarta VS; Borys DJ; Morgan DL
    Am J Ther; 2014; 21(4):244-9. PubMed ID: 23689094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanide poisoning and cardiac disorders: 161 cases.
    Fortin JL; Desmettre T; Manzon C; Judic-Peureux V; Peugeot-Mortier C; Giocanti JP; Hachelaf M; Grangeon M; Hostalek U; Crouzet J; Capellier G
    J Emerg Med; 2010 May; 38(4):467-76. PubMed ID: 20185266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cyanide antidotes in burn patients with suspected inhalation injuries in North America: a cross-sectional survey.
    Dumestre D; Nickerson D
    J Burn Care Res; 2014; 35(2):e112-7. PubMed ID: 23877146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility and outcomes of hydroxocobalamin use in smoke inhalation patients.
    Nguyen L; Afshari A; Kahn SA; McGrane S; Summitt B
    Burns; 2017 Feb; 43(1):107-113. PubMed ID: 27554631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraosseous versus intravenous infusion of hydroxocobalamin for the treatment of acute severe cyanide toxicity in a Swine model.
    Bebarta VS; Pitotti RL; Boudreau S; Tanen DA
    Acad Emerg Med; 2014 Nov; 21(11):1203-11. PubMed ID: 25377396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Methemoglobin Levels in a Patient Treated with Hydroxocobalamin After Suspected Cyanide Exposure.
    Kiernan E; Carpenter JE; Dunkley CA; Koch D; Morgan BW; Steck AR; Murray BP
    J Emerg Med; 2020 Nov; 59(5):e157-e162. PubMed ID: 33011041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanide Poisoning.
    Doman G; Aoun J; Truscinski J; Truscinski M; Aouthmany S
    J Educ Teach Emerg Med; 2022 Jul; 7(3):S1-S25. PubMed ID: 37465777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empiric management of cyanide toxicity associated with smoke inhalation.
    O'Brien DJ; Walsh DW; Terriff CM; Hall AH
    Prehosp Disaster Med; 2011 Oct; 26(5):374-82. PubMed ID: 22336184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory interferences with the newer cyanide antidote: hydroxocobalamin.
    Beckerman N; Leikin SM; Aitchinson R; Yen M; Wills BK
    Semin Diagn Pathol; 2009 Feb; 26(1):49-52. PubMed ID: 19292028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?
    Hall AH; Dart R; Bogdan G
    Ann Emerg Med; 2007 Jun; 49(6):806-13. PubMed ID: 17098327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxocobalamin interference in routine laboratory tests: Development of a protocol for identifying samples and reporting results from patients treated with Cyanokit
    Dang S; Tsui AK; Herndon R; Babiak C; Szkotak A; Füzéry AK; Raizman JE
    Clin Biochem; 2021 May; 91():31-38. PubMed ID: 33444605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.